The immunogenicity and safety of the BBIBP-CorV (Sinopharm) inactivated SARS-COV-2 vaccine: A prospective observational study in Indonesia

被引:0
|
作者
At Thobari, Jarir [1 ]
Sattwika, Prenali Dwisthi [2 ]
机构
[1] Univ Gadjah Mada, Dept Pharmacol & Therapy, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia
[2] Univ Gadjah Mada, Dept Internal Med, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1264
引用
下载
收藏
页码:597 / 597
页数:1
相关论文
共 50 条
  • [41] De novo severe pemphigus vulgaris following SARS-CoV-2 vaccination with BBIBP-CorV
    Saffarian, Zahra
    Samii, Rana
    Ghanadan, Alireza
    Vahidnezhad, Hassan
    DERMATOLOGIC THERAPY, 2022, 35 (06)
  • [42] Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
    Yuqi Zhu
    Xinyi Yang
    Jingna Xun
    Jun Liu
    Qing Wen
    Yixiao Lin
    Xiaoting Shen
    Jun Chen
    Songhua Yuan
    Xiaying Zhao
    Jing Wang
    Hanyu Pan
    Jinlong Yang
    Zhiming Liang
    Yue Liang
    Qinru Lin
    Huitong Liang
    Min Li
    Jianping Liu
    Yinzhong Shen
    Xiaoyan Zhang
    Pengfei Wang
    Daru Lu
    Chunhua Yin
    Jianqing Xu
    Shibo Jiang
    Hongzhou Lu
    Huanzhang Zhu
    Virologica Sinica, 2022, (06) : 831 - 841
  • [43] Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
    Yuqi Zhu
    Xinyi Yang
    Jingna Xun
    Jun Liu
    Qing Wen
    Yixiao Lin
    Xiaoting Shen
    Jun Chen
    Songhua Yuan
    Xiaying Zhao
    Jing Wang
    Hanyu Pan
    Jinlong Yang
    Zhiming Liang
    Yue Liang
    Qinru Lin
    Huitong Liang
    Min Li
    Jianping Liu
    Yinzhong Shen
    Xiaoyan Zhang
    Pengfei Wang
    Daru Lu
    Chunhua Yin
    Jianqing Xu
    Shibo Jiang
    Hongzhou Lu
    Huanzhang Zhu
    Virologica Sinica, 2022, 37 (06) : 831 - 841
  • [44] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 Vaccine BBIBP-CorV: a prospective multicentre observational cohort study
    Goebel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Muente, T.
    Goebel, H.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 113 - 113
  • [45] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 Vaccine BBIBP-CorV: a prospective multicentre observational cohort study
    Goebel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Muente, T.
    Goebel, H.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 76 - 76
  • [46] Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing
    Tong, Renyang
    Luo, Lingjie
    Zhao, Yichao
    Sun, Mingze
    Li, Ronghong
    Zhong, Jianmei
    Chen, Yifan
    Hu, Liuhua
    Li, Zheng
    Shi, Jianfeng
    Lyu, Yuyan
    Hu, Li
    Guo, Xiao
    Liu, Qi
    Shuang, Tian
    Zhang, Chenjie
    Yuan, Ancai
    Sun, Lingyue
    Zhang, Zheng
    Qian, Kun
    Chen, Lei
    Lin, Wei
    Chen, Alex F. F.
    Wang, Feng
    Pu, Jun
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [47] Immune response of booster doses of BBIBP-CORV vaccines against the variants of concern of SARS-CoV-2
    Mahmoud, Sally
    Ganesan, Subhashini
    Al Kaabi, Nawal
    Naik, Shivaraj
    Elavalli, Santosh
    Gopinath, Prem
    Ali, Alaa Mousa
    Bazzi, Lara
    Warren, Katherine
    Zaher, Walid Abbas
    Al Hosani, Farida
    JOURNAL OF CLINICAL VIROLOGY, 2022, 150
  • [48] Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study
    Tawinprai, Kriangkrai
    Siripongboonsitti, Taweegrit
    Porntharukchareon, Thachanun
    Vanichsetakul, Preeda
    Thonginnetra, Saraiorn
    Niemsorn, Krongkwan
    Promsena, Pathariya
    Tandhansakul, Manunya
    Kasemlawan, Naruporn
    Ruangkijpaisal, Natthanan
    Banomyong, Narin
    Phattraprayoon, Nanthida
    Ungtrakul, Teerapat
    Wittayasak, Kasiruck
    Thonwirak, Nawarat
    Soonklang, Kamonwan
    Sornsamdang, Gaidganok
    Mahanonda, Nithi
    VACCINES, 2022, 10 (05)
  • [49] Neutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination
    Zhang, Yuwei
    Guo, Xingyu
    Han, Shanshan
    Yao, Mingxiao
    Zhang, Lin
    Zhao, Lianxiang
    Zhang, Jinzhong
    Jiang, Xiangkun
    Zhang, Shu
    Pang, Bo
    Wang, Jianxing
    Wang, Shuang
    Fang, Ming
    Liu, Xiaolin
    Kou, Zengqiang
    Jiang, Xiaolin
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2023, 52
  • [50] The BBIBP-CorV inactivated COVID-19 vaccine induces robust and persistent humoral responses to SARS-CoV-2 nucleocapsid, besides spike protein in healthy adults
    Wang, Qinjin
    Ning, Jie
    Chen, Ying
    Li, Bin
    Shi, Liang
    He, Taojun
    Zhang, Fang
    Chen, Xingchi
    Zhai, Aixia
    Wu, Chao
    FRONTIERS IN MICROBIOLOGY, 2022, 13